Anti-PLD1 antibodies are used in the immunodetection of the protein phospholipase D1. In humans, the canonical protein has a reported length of 1074 amino acid residues and a mass of 124.2 kDa. Its subcellular localization is in the ER, Golgi, and cytoplasm. Up to 4 different isoforms have been reported for this protein. It is noted to be expressed abundantly in the pancreas and heart and at high levels in the brain, placenta, spleen, uterus and small intestine. A member of the Phospholipase D protein family, PLD1 is known to be involved with chemotaxis and the metabolism of lipids. Synonyms for this target antigen include CVDP1, choline phosphatase 1, phosphatidylcholine-hydrolyzing phospholipase D1, phospholipase D1, phosphatidylcholine-specific, and CVDD. PLD1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of PLD1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.